| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cero Therapeutics Holdings, Inc. (CERO) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 8 sells. CERO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.53M | $144.5K | - | |
| Other | 1.61M | $51.4K | - | |
| Dir | 1.61M | $51.4K | - | |
| CFO | 1.16M | $37.1K | - | |
| Dir | 690.9K | $22.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | Yk Bioventures Opportunities GP I, LLC | 10% Owner | Sell | 5,957,250 | $0.07 | $400,456.43 | -11.3% | |
| Dec 10, 2024 | Yk Bioventures Opportunities GP I, LLC | 10% Owner | Sell | 3,658,364 | $0.10 | $383,369.84 | -5.7% | |
| Oct 10, 2024 | Yk Bioventures Opportunities GP I, LLC | 10% Owner | Sell | 3,250,000 | $0.10 | $325,000.00 | -12.6% | |
| Sep 25, 2024 | Sloan Stuart M | 10% Owner | Sell | 532,486 | $0.10 | $55,538.29 | -2.5% |